Hyperhomocysteinemia may predispose to arterial and venous thrombosis.
Hyperhomocysteinemia may predispose to arterial thrombosis and venous thromboembolism, possibly because of injury to vascular endothelial cells (see Overview of Thrombotic Disorders), but some experts note that there is insufficient evidence definitively to link hyperhomocysteinemia to thrombosis. Plasma homocysteine levels are elevated ≥ 10-fold in homozygous cystathionine β-synthase deficiency. Milder elevations occur in heterozygous deficiency and in other abnormalities of folate metabolism, including methyltetrahydrofolate dehydrogenase deficiency. However, by far the most common causes of hyperhomocysteinemia are acquired deficiencies of
Folate deficiency is rare in the Western world due to folate fortification of wheat flour.
The abnormality is established by measuring plasma homocysteine levels.
Plasma homocysteine levels may be normalized by dietary supplementation with folate, vitamin B12, or vitamin B6 alone or in combination; however, it is not been shown that this therapy reduces the risk of arterial or venous thrombosis.
Last full review/revision October 2014 by Joel L. Moake, MD
Content last modified October 2014